These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9374852)
1. Four distinct cyclin-dependent kinases phosphorylate histone H1 at all of its growth-related phosphorylation sites. Swank RA; Th'ng JP; Guo XW; Valdez J; Bradbury EM; Gurley LR Biochemistry; 1997 Nov; 36(45):13761-8. PubMed ID: 9374852 [TBL] [Abstract][Full Text] [Related]
2. Trypanosoma cruzi histone H1 is phosphorylated in a typical cyclin dependent kinase site accordingly to the cell cycle. da Cunha JP; Nakayasu ES; Elias MC; Pimenta DC; Téllez-Iñón MT; Rojas F; Muñoz MJ; Almeida IC; Schenkman S Mol Biochem Parasitol; 2005 Mar; 140(1):75-86. PubMed ID: 15694489 [TBL] [Abstract][Full Text] [Related]
3. Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro. Takaki T; Fukasawa K; Suzuki-Takahashi I; Semba K; Kitagawa M; Taya Y; Hirai H J Biochem; 2005 Mar; 137(3):381-6. PubMed ID: 15809340 [TBL] [Abstract][Full Text] [Related]
4. Differential stage-specific regulation of cyclin-dependent kinases during cambial dormancy in hybrid aspen. Espinosa-Ruiz A; Saxena S; Schmidt J; Mellerowicz E; Miskolczi P; Bakó L; Bhalerao RP Plant J; 2004 May; 38(4):603-15. PubMed ID: 15125767 [TBL] [Abstract][Full Text] [Related]
5. Enzyme-linked immunosorbent assay for distinct cyclin-dependent kinase activities using phosphorylation-site-specific anti-pRB monoclonal antibodies. Suzuki S; Tamai K; Yoshida S Anal Biochem; 2002 Feb; 301(1):65-74. PubMed ID: 11811968 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody specific for histone H1 phosphorylated by cyclin-dependent kinases: a novel immunohistochemical probe of proliferation and neoplasia. Burstein DE; Oami S; Dembitzer F; Chu C; Cernaianu G; Leytin A; Misilim E; Jammula SR; Strauchen J; Kohtz DS Mod Pathol; 2002 Jul; 15(7):705-11. PubMed ID: 12118107 [TBL] [Abstract][Full Text] [Related]
7. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin. Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. Pavletich NP J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191 [TBL] [Abstract][Full Text] [Related]
9. Activation of the Cdc42p GTPase by cyclin-dependent protein kinases in budding yeast. Sopko R; Huang D; Smith JC; Figeys D; Andrews BJ EMBO J; 2007 Oct; 26(21):4487-500. PubMed ID: 17853895 [TBL] [Abstract][Full Text] [Related]
10. Identification of an effector protein and gain-of-function mutants that activate Pfmrk, a malarial cyclin-dependent protein kinase. Chen Y; Jirage D; Caridha D; Kathcart AK; Cortes EA; Dennull RA; Geyer JA; Prigge ST; Waters NC Mol Biochem Parasitol; 2006 Sep; 149(1):48-57. PubMed ID: 16737745 [TBL] [Abstract][Full Text] [Related]
11. p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol. Knockaert M; Lenormand P; Gray N; Schultz P; Pouysségur J; Meijer L Oncogene; 2002 Sep; 21(42):6413-24. PubMed ID: 12226745 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of the Pro-X-Thr-Pro site in phosphatase inhibitor-2 by cyclin-dependent protein kinase during M-phase of the cell cycle. Li M; Stefansson B; Wang W; Schaefer EM; Brautigan DL Cell Signal; 2006 Aug; 18(8):1318-26. PubMed ID: 16377132 [TBL] [Abstract][Full Text] [Related]
13. Expression of cyclins and cdks throughout murine carcinogenesis. Yerly-Motta V; Contassot E; Pavy JJ; Tiberghien P; Hervé P Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1217-28. PubMed ID: 10643971 [TBL] [Abstract][Full Text] [Related]
14. In vivo phosphorylation of histone H1 variants during the cell cycle. Talasz H; Helliger W; Puschendorf B; Lindner H Biochemistry; 1996 Feb; 35(6):1761-7. PubMed ID: 8639656 [TBL] [Abstract][Full Text] [Related]
15. Histone kinase activities in normal and transformed mouse cells. Sykes DE; Hohmann P Cancer Biochem Biophys; 1985 Feb; 7(4):317-23. PubMed ID: 2983880 [TBL] [Abstract][Full Text] [Related]
16. Mitotic timing is differentially controlled by A- and B-type cyclins and by CDC6 associated with a El Dika M; Wechselberger L; Djeghout B; Benouareth DE; Jęderka K; Lewicki S; Zdanowski R; Prigent C; Kloc M; Kubiak JZ Int J Dev Biol; 2021; 65(7-8-9):487-496. PubMed ID: 34549800 [TBL] [Abstract][Full Text] [Related]
17. M phase-specific phosphorylation of histone H1.5 at threonine 10 by GSK-3. Happel N; Stoldt S; Schmidt B; Doenecke D J Mol Biol; 2009 Feb; 386(2):339-50. PubMed ID: 19136008 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the mitotic specific phosphorylation site of histone H1. Absence of a consensus sequence for the p34cdc2/cyclin B kinase. Gurley LR; Valdez JG; Buchanan JS J Biol Chem; 1995 Nov; 270(46):27653-60. PubMed ID: 7499230 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of linker histones by cAMP-dependent protein kinase in mitotic micronuclei of Tetrahymena. Sweet MT; Allis CD Chromosoma; 1993 Nov; 102(9):637-47. PubMed ID: 8306826 [TBL] [Abstract][Full Text] [Related]
20. Site-specific regulation of histone H1 phosphorylation in pluripotent cell differentiation. Liao R; Mizzen CA Epigenetics Chromatin; 2017; 10():29. PubMed ID: 28539972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]